Drug Promotion and Scientific Exchange: The Role of the Clinical Investigator
Kessler, David A.
New England Journal of Medicine. 1991 Jul 18; 325(3): 201-203.
Conventional methods of drug promotion -- such as print advertising, direct marketing by salespeople, and the distribution of written materials at meetings -- have increasingly been supplemented by nontraditional approaches that rely heavily on the involvement of researchers and other medical experts. To the extent that these activities are represented as independent educational efforts when they are in fact promotional, they can undermine the unbiased exchange of scientific information, raise questions of professional ethics, and violate the standards set by the Food and Drug Administration. An aggressive alliance between the FDA and the medical community is vital if scientific and educational activities are to retain their rigor and intellectual credibility. The FDA is determined to ensure that the promotional activities of pharmaceutical firms are identifiable as such and that they conform to the laws. To succeed at this demanding task, the agency needs the cooperation of the country's physicians.
Advertising; Conflict of Interest; Drug Industry; Drugs; Economics; Education; Ethics; Financial Support; Food; Government; Government Regulation; Health; Health Care; Industry; Investigators; Laws; Marketing; Mass Media; Medical Education; Methods; Physicians; Professional Ethics; Regulation; Researchers; Standards; Technical Expertise;
Showing items related by title, author, creator and subject.
Hoberman, David; La Puma, John; Cohen, Stephen N.; Mossinghoff, Gerald J.; Stryer, Daniel B.; Bero, Lisa A.; Kalish, Richard S.; Kessler, David A.; Rose, Janet L.; Temple, Robert J.; Schapiro, Renie; Griffin, Joseph P.; Stern, Robert S. (1995-04-13)